title: ATRA is effective to an acute promyelocytic leukemia patient without RARA gene rearrangement.
authors.forename: Xianmin
authors.initials: X
authors.lastname: Song
authors.forename: Shenglan
authors.initials: S
authors.lastname: Gong
authors.forename: Jie
authors.initials: J
authors.lastname: Chen
authors.forename: Lei
authors.initials: L
authors.lastname: Gao
authors.forename: Jianmin
authors.initials: J
authors.lastname: Yang
authors.forename: Jianmin
authors.initials: J
authors.lastname: Wang
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005260:Female; D015321:Gene Rearrangement; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D018168:Receptors, Retinoic Acid / Q000235:genetics*; D016896:Treatment Outcome; D014212:Tretinoin / Q000627:therapeutic use*; D055815:Young Adult
chemical_list: D000970:Antineoplastic Agents; D018168:Receptors, Retinoic Acid; D014212:Tretinoin